PRLX-43318 compound series (Prolexys Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRLX-43318 compound series (Prolexys Pharmaceuticals)
Drug Alias NamePRLX-43318 analogs (Prolexys Pharmaceuticals)beta-catenin activity inhibitors (Prolexys Pharmaceuticals)PRLX-43318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 modulators
TargetsCatenin beta 1
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProlexys Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProlexys Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A